The US Food and Drug Administration (FDA) on Thursday announced it will publish complete response letters (CRLs) detailing the reasons for a product’s rejection soon after they are issued to ...
In a marked departure from long-standing practice, the US Food and Drug Administration (FDA) has begun publishing stand-alone complete response letters (CRLs), formal communications that detail the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results